SHANGHAI, Jan. 27, 2026 /PRNewswire/ — For decades, visiting Shanghai meant following a familiar set of stops: the Bund at sunset, a stroll through Yuyuan Garden, perhaps a first glimpse of the skyline from Pudong. Increasingly, though, the city wants travelers to move beyond the checklist — and to describe Shanghai in their own words.

That shift is on display in a citywide tourism guide competition launched last November, which invited participants to document how they experience Shanghai, from classic sightseeing routes to more personal, idiosyncratic discoveries. In less than two months, the contest drew more than 8,900 submissions, many of them shared widely online, with related videos and posts viewed hundreds of millions of times.

Rather than focusing solely on travel agencies and industry influencers, the competition opened its doors to the public, placing curated itineraries alongside accounts shaped by everyday experiences — neighborhood walks, food discoveries, and encounters that don’t always appear in traditional guidebooks. Together, they offered a portrait of a city that is at once well known and still in the process of being rediscovered.

The timing is deliberate. As the Lunar New Year approaches, Shanghai has rolled out a dense calendar of events across the city, including thousands of cultural activities and performances, accompanied by seasonal promotions from attractions, hotels, guesthouses, and travel agencies. The aim is less about drawing visitors for a single landmark than about encouraging longer stays and repeat visits, particularly during one of China’s busiest travel periods.

What emerges from these efforts is a broader recalibration of how the city presents itself to travelers, both from within China and abroad. By encouraging visitors to explore beyond established routes — and to share what they find — Shanghai is betting that personal stories can carry more weight than official narratives.

In doing so, the city is aligning itself with a wider shift in global travel, where tourists increasingly seek experiences that feel specific, lived-in, and worth retelling. For Shanghai, the hope is that these stories linger well beyond the trip itself, shaping how the city is remembered — and why travelers choose to return.

• Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease.
• License and collaboration agreement strengthen Boehringer’s inflammatory disease pipeline with a potential, first-in-class, pre-clinical asset.
• Boehringer receives global rights to the asset, excluding greater China; Simcere is eligible to receive payments of up to EUR 1,058 million

SHANGHAI, Jan. 27, 2026 /PRNewswire/ — Simcere Pharmaceutical Group Ltd. (“Simcere”) (HKEX: 2096) and Boehringer Ingelheim, today announced a license and collaboration agreement to develop SIM0709, a pre-clinical TL1A/IL23p19 bispecific antibody from Simcere, for the treatment of inflammatory bowel disease (IBD).

Globally, it is estimated that more than three million people are affected by IBD, a lifelong, progressive condition leading to frequent hospitalization and surgeries, significantly impacting patients’ quality of life. Current medical options cannot fully prevent or reverse these complications, leaving a clear unmet need. Through this partnership, Boehringer and Simcere aim to advance an innovative approach to potentially redefine treatment possibilities and improve outcomes for patients worldwide.

SIM0709 is a long-acting humanized bispecific antibody developed by Simcere using its proprietary multi-specific antibody platform. It simultaneously targets tumor necrosis factor ligand superfamily member 15 (TL1A) and interleukin-23 (IL-23), thereby blocking two core pathways that drive the onset and progression of IBD. Both in vitro primary cell studies and in vivo animal studies, SIM0709 demonstrated superior synergistic efficacy, even outperforming the combination of the two corresponding monotherapies.

Carine Boustany, US Innovation Unit Site Head and Global Head of Immunology and Respiratory Diseases at Boehringer Ingelheim said, “In IBD, too many patients continue to progress and experience severe complications despite currently available anti-inflammatory therapies. We are excited to join forces with Simcere to accelerate the development of this therapeutic as a potential life changing option for patients living with IBD.”

“Simcere’s bispecific antibody SIM0709 was engineered with our proprietary multi-specific antibody platform with first-in-class potential for IBD treatment. Partnering with Boehringer Ingelheim, with its long‑term commitment and deep expertise in immunology, positions the compound for rigorous global development,” said Gaobo Zhou, Chief Investment Officer, Simcere Pharmaceutical Group. “Together we aim to accelerate the clinical development and advance a treatment option that could improve outcomes for patients world-wide affected by IBD.”

Under the terms of the agreement Boehringer receives global rights to the asset, excluding greater China. Simcere is eligible to receive an upfront payment as well as success-based development, regulatory and sales milestones up to EUR 1,058 million, as well as royalties on net sales outside of the Greater China territory.

This marks Simcere’s second out- licensing transaction in the autoimmune field. As of January 2026, Simcere has completed a total of 5 out-licensing deals for its self-developed novel drug technologies, with a total potential transaction value of approximately $4.6 billion.

About Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limited（2096.HK）is a pharmaceutical company driven by innovation and focusing on four therapeutic areas including Neuroscience, Oncology, Autoimmune Diseases and Anti-infection. We proactively explore areas with significant unmet needs, and our mission is For patients, for life. Driven by our in-house R&D efforts and synergistic innovation, Simcere has established strategic cooperation partnerships with many innovative companies and research institutes. Learn more at www.simcere.com.

About Boehringer Ingelheim

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com.

EL DORADO HILLS, Calif. and SINGAPORE, Jan. 27, 2026 /PRNewswire/ — Blaize Holdings, Inc. (Nasdaq: BZAI, Nasdaq: BZAIW) (“Blaize”), a global leader in programmable, energy efficient AI computing, today announced a strategic Memorandum of Understanding (MOU) with Nokia Solutions and Networks Singapore Pte. Ltd. (“Nokia”), a company duly incorporated and validly existing under the laws of Singapore.

Targeting the Asia Pacific markets, the MOU establishes a framework for joint exploration, development, and deployment of Practical AI and Physical AI systems designed for real world operation, combining Nokia’s leadership in networking, automation, and cloud infrastructure with Blaize’s programmable AI inference platform. Together, the companies aim to enable Real World AI that operates reliably at the edge and across hybrid environments where latency, power efficiency, and operational resilience are critical.

Under the MOU, Blaize and Nokia intend to collaborate on:

• Edge and hybrid AI inference use cases, integrating Blaize’s Hybrid AI platform with Nokia’s IP networking, data center networking, and automation systems
• Reference architectures and solution blueprints that position Blaize as a complementary AI inference layer alongside Nokia’s AI networking infrastructure
• Joint validation of AI inference deployments for telecom, industrial, and smart infrastructure environments
• Go to market and ecosystem initiatives, including customer workshops, pilot programs, and solution demonstrations focused on production ready AI

The collaboration reflects a shared belief that the next phase of AI adoption will be driven by inference at scale, not just model training. By pairing energy efficient AI inference at the edge with centralized GPU resources in the cloud, Blaize and Nokia are addressing the growing demand for Hybrid AI architectures that balance performance, cost, and operational efficiency.

“Our collaboration with Nokia marks an important step forward in delivering Practical AI and Physical AI at scale,” said Dinakar Munagala, Co-Founder and Chief Executive Officer of Blaize. “By combining Nokia’s leadership in connectivity and automation with the Blaize AI inference platform, we are enabling Real World AI that runs efficiently at the edge while integrating seamlessly with cloud and GPU infrastructure. This Hybrid AI approach allows organizations to deploy inference where it matters most and turn intelligence into real operational outcomes.”

Nokia intends to contribute its expertise in networking, automation, and cloud infrastructure, including leadership in IP networking, industrial connectivity, and intelligent network operations. Blaize intends to provide its AI inference hardware and software platform, designed to complement GPU based systems by enabling scalable, low power inference closer to where data is generated, and actions are taken.

“Our work with Blaize is accelerating, and we are excited to build on this momentum into the coming year,” said Sang Xulei, Senior Vice President and Head of Network Infrastructure, Asia Pacific at Nokia. “As demand grows for Practical AI and Physical AI systems that operate in real world environments, Blaize’s energy efficient AI inference platform gives us the flexibility to extend Hybrid AI architectures across networks, edge systems, and cloud infrastructure. Together, we are enabling scalable, production ready intelligence that brings AI closer to where data is generated and actions are taken in the region.”

The collaboration leverages Blaize’s specialized AI inference platform, chosen for its ability to support real world AI deployment across edge, cloud, and data center environments.

The MOU is non-binding and outlines a cooperative framework under which the parties may pursue specific projects through future definitive agreements in the Asia Pacific region. The collaboration will focus on enabling secure, scalable, and energy efficient AI inference deployments that integrate seamlessly into existing network, cloud, and industrial environments.

About Blaize

Blaize delivers a programmable AI platform, purpose-built for inference in real world environments. Its Hybrid AI architecture enables Practical AI and Physical AI workloads to run efficiently at the edge while integrating seamlessly with cloud and GPU based infrastructure. Blaize solutions support computer vision, multimodal AI, and sensor driven applications across smart cities, industrial automation, telecommunications, retail, logistics, and defense. Blaize is headquartered in El Dorado Hills, California, with a global presence across North America, Europe, the Middle East, and Asia.

About Nokia

Nokia is a global leader in connectivity for the AI era. With expertise across fixed, mobile, and transport networks, we’re advancing connectivity to secure a brighter world.

Cautionary Statement Regarding Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are based on beliefs and assumptions and on information currently available to Blaize, including statements regarding the the expected scope of the engagement with Nokia and any potential definitive agreements related thereto; the industry in which Blaize operates, market opportunities, and product offerings. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” “target,” “seek” or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this document, including but not limited to: (i) changes in domestic and foreign business, market, financial, political and legal conditions; (ii) failure to realize the anticipated benefits of Blaize’s business combination with BurTech Acquisition Corp., which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; and (iii) those factors discussed under the heading “Risk Factors” in our Annual Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) on April 15, 2025, our and other documents filed by Blaize from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Blaize assumes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law, including the securities laws of the United States and the rules and regulations of the SEC. Blaize does not give any assurance that it will achieve its expectations.

For media inquiries:

press@blaize.com

www.blaize.com

PROVIDENCIALES, Turks and Caicos Islands, Jan. 27, 2026 /PRNewswire/ — KuCoin Web3 today announced a major functional upgrade and the official launch of the KuCoin Web3 Wallet. This self-custodial solution is engineered to simplify the transition between centralized and decentralized finance. Currently supporting 20 major blockchain networks, the wallet is available across mobile apps, browser extensions, and web platforms and offers a unified experience that combines asset management, token swaps, yield opportunities, airdrop access, smart money insights, and a built-in DApp browser.

The core enhancement of this upgrade is the integration of native perpetual futures trading, powered by Hyperliquid’s low-latency infrastructure. This allows users to execute trades with real-time price updates and performance levels comparable to centralized exchanges, all while maintaining full custody of their private keys. The integration supports more than 190 perpetual trading pairs and multiple leverage options. Designed to lower the learning curve for new users by streamlining the trading experience, the features remain robust for advanced traders who can manage complex functions, such as take-profit and stop-loss orders, through an interface specifically optimized for professional mobile use.

Addressing the growing challenge of Web3 fragmentation, the wallet consolidates core decentralized functionalities into a single interface, eliminating the need for users to navigate multiple external applications. By bridging centralized exchange liquidity with decentralized execution, the platform provides a seamless flow between asset management and active on-chain trading.

The wallet provides multi-chain support to over 1,000 digital assets, with additional networks to be added in the future. KuCoin Web3 Wallet integrated with the CEX ecosystem to enable effortless asset transfers, while biometric authentication and encrypted cloud backup technology ensure robust security without compromising the principles of self-sovereignty.

KuCoin Web3 committed to simplify the Web3 experience without compromising on the standards of trust and liquidity that global users expect. By providing a high-performance gateway to decentralized markets, KuCoin Web3 continues to build the necessary infrastructure for a transparent and user-centric financial future.

About KuCoin Web3 Wallet

KuCoin Web3 Wallet is a decentralized, non-custodial wallet that supports multiple blockchains. Designed with security and on-chain alpha at its core, it features a built-in cross-chain swap aggregator DEX for seamless trading across networks, along with Smart Money tools to help you spot early opportunities. With access to over 1,000 DApps and a dedicated airdrop hub featuring trending and newly listed tokens, KuCoin Web3 Wallet serves as your ultimate all-in-one gateway to the Web3 world.

Learn more: X | Telegram